Complementary Alternative Cardiovascular Medicine

Recommendations

Info

70 Alternative Cardiovascular Medicine 38. Pullin CH, Ashfield-Watt PA, Burr ML, et al. Optimization of dietary folate or low dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 2001;38:1799–1805. 39. Nakano E, Higgins JA, Powers HJ. Short communication. Folate protects against oxidative modification of human LDL. Br J Nutr 2001;86:637–639. 40. Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis with lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593–1600. 41. Schnyder G, Roffi M, Flammer Y, et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B 12 and vitamin B 6 on clinical outcome after percutaneous coronary intervention. JAMA 2002;288:973–979. 42. Genser D, Pracher H, Hauer R, et al. Relation of homocysteine, vitamin B 12 and folate to coronary in-stent restenosis. Am J Cardiol 2002;89:495–499. 43. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001;73:673–686. 44. Katz DL, Nawaz H, Boukhalil J, et al. Acute effects of oats and vitamin E on endothelial responses to ingested fat. Am J Prev Med 2001;20:124–129. 45. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial function after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999;99:1156–1160. 46. Skyrme-Jones RA, O’Brien OC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 2000;36:94–102. 47. Kugiyama K, Motoyama T, Doi H, et al. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoprotein levels. J Am Coll Cardiol 1999;33:1512–1518. 48. Richartz BM, Werner GS, Ferrari M, Figulla HR. Reversibility of coronary endothelial vasomotor dysfunction in idiopathic dilated cardiomyopathy; acute effects of vitamin C. Am J Cardiol 2001;88:10001–1005. 49. Rossig L, Hoffmann J, Hugel B, et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001;104:2181–2187. 50. Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on Progression of transplant associated arteriosclerosis: a randomized trial. Lancet 2002;359:1108–1113. 51. McKechnie R, Rubenfire M, Mosca L. Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease. Lab Clin Med 2002;139;133–139. 52. Canner PL, Berge KG,Winger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long term benefits with niacin. J Am Coll Cardiol 1986;8:1245–1255. 53. Schectman G, Hiatt A. Evaluation of the effectiveness of lipid lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans. Am J Cardiol 1993;71:758–765. 54. Ellingworth DR, Stein EA, Mitchell YB, et al. Comparative effects of lovastatin and niacin in primary hypercholesterolemia: a prospective trial. Arch Intern Med 1994;154:1586–1595. 55. Davignon J, Raederer G, Montigny M, et al. Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia. Am J Cardiol 1994;73:339–345. 56. Jokubaitis LA. Fluvastatin in combination and other lipid-lowering agents. Br J Clin Pract 1996;77A(suppl):28–32. 57. Jacobson TA, Chin MM, Fromel GJ, Jokubaitis LA, Amorosa LF. Fluvastatin with and without niacin for hypercholesterolemia. Am J Cardiol 1994;74:149–154.
Chapter 5 / Vitamin Therapy and CVD 71 58. Vacek JL, Dittmeier G, Chiarelli T, White J, Bell JJ. Comparison of lovastatin (20mg) and nicotinic acid (1.2) with either drug for type 11 hyperlipidemia. Am J Cardiol 1995;76:182–184 59. Wink J, Giacoppe G, King J. Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy. Am Heart J 2002;143:514–518. 60. Institute of Medicine Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC, 2000. 61. Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown G. Antioxidant supplements block the response of HDL to Simvastatin-Niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 2001;21;1320–1326. 62. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 2002;162:1472–1476.
Page 1 and 2:
Complementary and Alternative Cardi
Page 3 and 4:
CONTEMPORARY CARDIOLOGY CHRISTOPHER
Page 5 and 6:
© 2004 Humana Press Inc. 999 River
Page 7 and 8:
vi Preface physician or other healt
Page 9 and 10:
viii Contents 10 Massage Therapy an
Page 11 and 12:
x Contributors ERIN L. OLIVO, PhD
Page 13 and 14:
Chapter 1 / CAM and CVD 1 1 Complem
Page 15 and 16:
Chapter 1 / CAM and CVD 3 patients
Page 17 and 18:
Chapter 1 / CAM and CVD 5 The crite
Page 19 and 20:
Chapter 1 / CAM and CVD 7 disease c
Page 21:
Chapter 1 / CAM and CVD 9 analyses,
Page 24 and 25:
12 Alternative Cardiovascular Medic
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33: 20 Alternative Cardiovascular Medic
Page 39 and 40: Chapter 3 / Botanical Medicine and
Page 61 and 62: Chapter 4 / Herb and Dietary Supple
Page 71 and 72: Chapter 5 / Vitamin Therapy and CVD
Page 81: Chapter 5 / Vitamin Therapy and CVD
Page 100 and 101: Table 2 Type and Quantity of Dietar
Page 102 and 103: Table 2 (Continued) Type and Quanti
Page 112 and 113: 100 Alternative Cardiovascular Medi
Page 132 and 133:
120 Alternative Cardiovascular Medi
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 165 and 166:
Chapter 10 / Massage Therapy and CV
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Chapter 11 / Acupuncture and CVD 16
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 251 and 252:
Chapter 15 / Aromatherapy and CVD 2
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Chapter 16 / A Guide for Physicians
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Index 279 INDEX A N-Acetylcysteine
Page 293 and 294:
Index 281 taurine studies, 106 Conj
Page 295 and 296:
Index 283 Homeopathic medicine, see
Page 297 and 298:
Index 285 funding of studies, 148 g
Page 299:
Contemporary Cardiology COMPLEMENTA
show all

Complementary Alternative Cardiovascular Medicine

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?